Iron: Regulation, redox homeostasis, and ferroptosis in cancer
Ferroptosis and Oxidative Stress · 2025
DOI: 10.70401/fos.2026.0022 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ferroptosis and Oxidative Stress, 2025. Verfasst von Chesta Jain und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIDDK NIH HHS.
Abstract (Originalsprache)
Iron is essential for cellular metabolism, redox balance, and proliferation, yet its redox activity generates reactive oxygen species (ROS) that can damage DNA, proteins, and lipids. Cancer cells exploit iron homeostasis mechanisms, including iron regulatory proteins, ferritinophagy, and hypoxia-inducible factors to maintain high intracellular iron, supporting metabolic reprogramming, antioxidant defenses, and therapy resistance. Iron-dependent lipid peroxidation drives ferroptosis, a regulated form of cell death uniquely dependent on iron. Ferroptosis is tightly controlled by metabolic and antioxidant pathways and mitochondrial ROS, as well as by lipid composition and polyunsaturated fatty acid availability. Ferroptosis also intersects with apoptosis and necroptosis, highlighting the central role of iron in cell fate and survival. Dysregulation of these pathways in cancer can sensitize cells to ferroptosis, creating a therapeutic vulnerability. Exploiting ferroptosis through modulation of iron availability, redox defenses, or lipid metabolism offers a promising anticancer strategy. However, tissue-specific iron dynamics, tumor heterogeneity, and interactions within the tumor microenvironment complicate clinical translation. Integrative approaches combining metabolic profiling, genetic analysis, and ferroptosis-targeted interventions will be critical to harness iron-dependent cell death while minimizing systemic toxicity. In this review, we explore the mechanisms through which cancer cells sustain high iron, evading associated toxicities and possible implications for integrating ferroptosis based therapies in clinical oncology.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Internal Medicine, Division of Gastroenterology and Hepatology, Michigan Medicine at the University of Michigan, Ann Arbor, MI 48109, USA.
- Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
Förderung
- NCI NIH HHS
- NIDDK NIH HHS
Zitieren
APA
Jain, C., & Shah, Y. M. (2025). Iron: Regulation, redox homeostasis, and ferroptosis in cancer. Ferroptosis and Oxidative Stress. https://doi.org/10.70401/fos.2026.0022
Vancouver
Jain C, Shah YM. Iron: Regulation, redox homeostasis, and ferroptosis in cancer. Ferroptosis and Oxidative Stress. 2025. doi:10.70401/fos.2026.0022
BibTeX
@article{Jain2025,
author = {Jain, Chesta and Shah, Yatrik M},
title = {Iron: Regulation, redox homeostasis, and ferroptosis in cancer},
journal = {Ferroptosis and Oxidative Stress},
year = {2025},
doi = {10.70401/fos.2026.0022}
}
EUVIMED